Microsoft (MSFT), SAP (SAP), and a number of Brazilian banks reportedly had neutral opinions on the deal, while Oracle (ORCL) had some concerns.
The deal still needs to secure the approval of EU regulators, the report said.
(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)
Price: 135.61, Change: +0.74, Percent Change: +0.55
|Aevi Genomic Medicine In Deal with Astellas to Devel...|
|Insider Trends: Insider at CareDx Converts Options i...|
|Close Update: US Stocks Struggle for Direction, Clos...|
|Arbutus Biopharma Reports No Major Negative Effects ...|
|Arrow Electronics Preliminary Q2 Disappoints on Weak...|